Atalanta Sosnoff Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $82.5M | Buy |
642,053
+339,926
| +113% | +$39.8M | 1.45% | 28 |
|
|
2026
Q1 | $36.3M | Buy |
302,127
+175,167
| +138% | +$20.2M | 0.78% | 41 |
|
|
2025
Q4 | $13.4M | Buy |
+126,960
| New | +$11.9M | 0.26% | 46 |
|
|
2025
Q1 | – | Sell |
-8,755
| Closed | -$871K | – | 113 |
|
|
2024
Q4 | $871K | Sell |
8,755
-371,761
| -98% | -$38.3M | 0.02% | 63 |
|
|
2024
Q3 | $43.2M | Sell |
380,516
-204,404
| -35% | -$24.3M | 0.93% | 39 |
|
|
2024
Q2 | $72.4M | Sell |
584,920
-2,266
| -0.4% | -$292K | 1.63% | 20 |
|
|
2024
Q1 | $77.5M | Sell |
587,186
-3,143
| -0.5% | -$387K | 1.79% | 13 |
|
|
2023
Q4 | $64.4M | Sell |
590,329
-6,884
| -1% | -$715K | 1.66% | 19 |
|
|
2023
Q3 | $61.5M | Sell |
597,213
-288,398
| -33% | -$31.1M | 1.82% | 13 |
|
|
2023
Q2 | $102M | Sell |
885,611
-20,788
| -2% | -$2.36M | 2.77% | 9 |
|
|
2023
Q1 | $96.4M | Sell |
906,399
-23,908
| -3% | -$2.58M | 2.8% | 7 |
|
|
2022
Q4 | $103M | Sell |
930,307
-120,106
| -11% | -$12.3M | 3.18% | 5 |
|
|
2022
Q3 | $90.5M | Sell |
1,050,413
-90,650
| -8% | -$8.09M | 2.85% | 8 |
|
|
2022
Q2 | $104M | Sell |
1,141,063
-12,525
| -1% | -$1.11M | 3.14% | 7 |
|
|
2022
Q1 | $94.7M | Buy |
1,153,588
+267,853
| +30% | +$21.1M | 2.22% | 8 |
|
|
2021
Q4 | $67.9M | Buy |
885,735
+401,858
| +83% | +$32M | 1.46% | 22 |
|
|
2021
Q3 | $36.3M | Buy |
+483,877
| New | +$36.8M | 0.85% | 40 |
|
|
2020
Q4 | – | Sell |
-543,343
| Closed | -$43M | – | 107 |
|
|
2020
Q3 | $43M | Sell |
543,343
-7,937
| -1% | -$622K | 1.22% | 31 |
|
|
2020
Q2 | $40.7M | Sell |
551,280
-15,170
| -3% | -$1.14M | 1.23% | 29 |
|
|
2020
Q1 | $41.6M | Buy |
566,450
+8,644
| +2% | +$679K | 1.48% | 24 |
|
|
2019
Q4 | $48.4M | Sell |
557,806
-6,121
| -1% | -$503K | 1.44% | 23 |
|
|
2019
Q3 | $45.3M | Buy |
563,927
+202,070
| +56% | +$16.2M | 1.47% | 26 |
|
|
2019
Q2 | $29M | Buy |
+361,857
| New | +$27.7M | 0.91% | 47 |
|
|
2017
Q4 | – | Sell |
-21,007
| Closed | -$1.28M | – | 95 |
|
|
2017
Q3 | $1.28M | Sell |
21,007
-14,211
| -40% | -$862K | 0.04% | 64 |
|
|
2017
Q2 | $2.15M | Buy |
35,218
+999
| +3% | +$60.8K | 0.08% | 65 |
|
|
2017
Q1 | $2.08M | Buy |
34,219
+885
| +3% | +$53.7K | 0.07% | 68 |
|
|
2016
Q4 | $1.87M | Sell |
33,334
-389,560
| -92% | -$22.8M | 0.07% | 76 |
|
|
2016
Q3 | $25.2M | Sell |
422,894
-33,571
| -7% | -$1.96M | 0.87% | 49 |
|
|
2016
Q2 | $25.1M | Sell |
456,465
-36,890
| -7% | -$1.96M | 0.84% | 50 |
|
|
2016
Q1 | $24.9M | Sell |
493,355
-289,310
| -37% | -$14.2M | 0.78% | 50 |
|
|
2015
Q4 | $39.4M | Sell |
782,665
-40,579
| -5% | -$2.05M | 1.17% | 36 |
|
|
2015
Q3 | $38.8M | Sell |
823,244
-33,717
| -4% | -$1.79M | 1.24% | 38 |
|
|
2015
Q2 | $46.6M | Sell |
856,961
-77,943
| -8% | -$4.37M | 1.28% | 34 |
|
|
2015
Q1 | $51.3M | Sell |
934,904
-46,288
| -5% | -$2.62M | 1.37% | 34 |
|
|
2014
Q4 | $53.2M | Sell |
981,192
-96,379
| -9% | -$5.37M | 1.31% | 36 |
|
|
2014
Q3 | $61M | Sell |
1,077,571
-179,758
| -14% | -$10.1M | 1.51% | 32 |
|
|
2014
Q2 | $69.4M | Buy |
1,257,329
+1,216,904
| +3,010% | +$66.4M | 1.52% | 27 |
|
|
2014
Q1 | $2.19M | Buy |
40,425
+6,833
| +20% | +$354K | 0.05% | 57 |
|
|
2013
Q4 | $1.6M | Buy |
+33,592
| New | +$1.54M | 0.03% | 72 |
|
Other funds holding MRK
Atalanta Sosnoff Capital's MRK Position: Q2 2026 in Review
Atalanta Sosnoff Capital increased its Merck (MRK) stake by 113% in Q2 2026, buying an estimated $39.8M and bringing the position to 642,053 shares worth $82.5M. The position accounts for 1.45% of the portfolio, ranked #28.
Atalanta Sosnoff Capital first reported a position in MRK in Q4 2013 and has held it in 39 quarters since. The position peaked at $104M in Q2 2022. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Atalanta Sosnoff Capital held 642,053 shares of Merck worth $82.5M as of Q2 2026.
- Atalanta Sosnoff Capital bought 339,926 Merck shares in Q2 2026, an estimated $39.8M.
- Merck made up 1.45% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #28 holding.
- Atalanta Sosnoff Capital first reported a position in Merck in Q4 2013 and has held it in 39 quarters since.
- Atalanta Sosnoff Capital's Merck position peaked at $104M in Q2 2022.
- 3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.